Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells

NCT02213705 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

SYSTEMIC SCLERODERMA
ALLOGENEIC MESENCHYMAL STEM CELLS
ADULT

Interventions

BIOLOGICAL: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS

Sponsor

Assistance Publique - Hôpitaux de Paris